0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Clinical Research |

Nebulette Mutations in Cardiac Remodeling: Big Effects From a Small Mechanosensor FREE

Rashmi Ram, PhD; Burns C. Blaxall, PhD
[+] Author Information

Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Funding was provided by the National Institutes of Health (1R01 HL089885 and 3R01 HL089885). The authors report they have no relationships with industry to disclose.Reprint requests and correspondence: Dr. Burns C. Blaxall, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box CVRI, Rochester, New York 14642

American College of Cardiology Foundation

J Am Coll Cardiol. 2010;56(18):1503-1505. doi:10.1016/j.jacc.2010.06.031
Published online

Within the cytoskeletal framework of the heart, sarcomeres form the contractile machinery of cardiac muscle. Proteins associated with the thick and thin filaments and the Z-disk participate in maintenance of the sarcomere structure. The Z-disks connect with integrins and dystroglycan of the sarcolemma, allowing transmission of force generated by myofilaments to the adjacent sarcomeres, the extracellular matrix, and ultimately, to other cells. Additionally, proteins shuttling between sarcomeric and nonsarcomeric locales convey signals from the contractile machinery to the nucleus (1). These highly coordinated and overlapping functions of the cytoskeletal machinery enable rapid adjustments in cardiac muscle to changes in physiological requirements. Mutations of several proteins associated with sarcomere, Z-disk, and cytoskeletal assembly and function cause dilated cardiomyopathy (DCM) and heart failure (2). Considering the important role of the Z-disk in cardiac homeostasis, it is not surprising that mutations in Z-disk proteins not only alter its physical connection with myofilaments and cytoskeletal proteins, but also affect the generation and transmission of mechanical and biochemical signals.

Nebulette, the cardiac isoform of the giant (>600 kDa) actin-binding protein nebulin (found in skeletal muscle), is localized to, and predicted to extend <150 nm beyond, the Z-disk. Nebulette consists of a short N-terminal domain and 22 nebulin-like repeats that are connected to a C-terminal SH3 domain by a short linker domain (3). Overexpression of the linker or SH3 domains in chicken embryonic cardiomyocytes resulted in a loss of endogenous nebulette and a decrease in filament length (45), suggesting a role for nebulette in both thin filament and Z-disk assembly, function, and stability (3,56). Nebulette interacts with a large number of thin filament-associated and Z-disk–associated proteins (3). The central repeat domains associate with actin, troponin, and tropomyosin; the SH3 domain interacts with actin, α-actinin (7), CapZ, titin, myopalladin, zyxin (8), desmin (9), and filamin C (10).

In this issue of the Journal, Purevjav et al. (11) have described de novo nebulette mutations in patients with DCM and endocardial fibroelastosis (EFE). The data in part support the authors' prior proposal that genes encoding cytoskeletal and sarcomeric proteins represent a major component of the “final common pathway” in the development of heart failure (12). Previously, nebulette polymorphisms have been linked with nonfamilial DCM (13); this study identifies 4 individual, de novo mutant variants of the human nebulette gene (1, K60N, had been previously reported in dbSNP; rs41277374). Two of the 4 mutations reside in the actin-binding domain (K60N, Q128R); the other 2 are located within the nebulin-like repeat region (G202R, A592E). Importantly, human cardiac disease phenotypes were recapitulated in cardiac-targeted transgenic mouse models: cardiac expression of K60N or Q128R mutations resulted in embryonic lethality, whereas the other 2 (G202R, A592E) led to progressive DCM. This confirmatory in vivo transgenic mouse data revealed distinct cytoskeletal changes and myofibrillar organization resulting from various nebulette mutations, and suggests roles of nebulette in early cardiac development. Finally, the effect of nebulette mutations on nebulette subcellular distribution and the effect of cyclical mechanical stretch was assessed in embryonic rat cardiomyoblasts.

In the present study (11), the authors identify multiple, isolated mutations in a single nebulette gene, revealing distinct Z-disk genotypes affiliated with distinct DCM phenotypes in both humans and transgenic mice. With the recent identification of numerous Z-disk mutations, genotype/phenotype analyses such as those outlined in the current study may help further identify, validate, and/or stratify genetic subsets of DCM patients, possibly extending the screening benefit to the patient's immediate and extended families. The divergence in DCM phenotype across the 4 identified nebulette mutations (functionally validated in cardiac transgenic mice) reflects the multiple roles of nebulette in modulating cardiomyocyte stretch-strain with distinct structural/cytoskeletal modifications.

Each region of nebulette appears to be critical for myofibrillar assembly and stability. Functional mutations within the nebulin-like repeat region (such as of the G202R and A592E mutations described by the authors) affect maintenance and stabilization of the Z-disk assembly (14). Defective force generation and force transmission are widely proposed pathophysiological models of DCM (15). The cytoskeleton is a dynamic, adaptive structure that physically links the contractile machinery to the extracellular matrix. While changes in sarcomere/calcium handling proteins can affect actin-myosin interactions (16) and force generation such as in the G202/Q128R mice, alterations in cytoskeletal proteins (A592E mice) reduce force transmission efficiency (17). Given the unique properties of nebulette's interaction with both cytoskeletal and sarcomeric proteins across different domains, loss of coordinated interaction between the sarcomere, cytoskeleton, and the sarcolemma may result in reduced cardiac contractile function, ultimately leading to pathologic cardiac hypertrophy and cardiomyopathy.

As previously described, the Z-disk, well recognized as a specialized stretch-interpreting sensor (18), enables the cardiomyocyte to sense increased mechanical load and respond with multiple changes, including altered gene expression, resulting in pathologic hypertrophy that decompensates into heart failure. Nebulette consistently associates with the Z-disk assembly, persisting from genesis of the myofibril of developing cardiac muscle (7) to its final position at the Z-disk in the mature heart. The authors (11) highlight that, during cyclic mechanical strain, nebulette is initially localized to the perinuclear region, followed by its distribution along F-actin filaments reaching the cell periphery. In contrast, mutant nebulette proteins preferentially localized to the perinuclear region, with delayed expression of this mutant along maturing actin filaments. Further, in the Q128R mutants, nebulette appeared to be dissociated from Z-disks, accompanied by a loss of desmin.

Calcineurin and NFAT are emerging candidate messengers responsible for transmission of stretch signals from Z-disks to the nucleus (18). Mechanical stretch can lead to activation of multiple stretch-activated kinase cascades, as well as changes in the activity of various ion channels/exchangers, presumably all as a result of an acute hypertrophic process. Desmin, a major cytoarchitectural protein also residing at both the Z-disk and intercalated disk, is known to play a vital role in transmitting longitudinal stretch signals (19). Nebulette, in its position at the nexus of sarcomeric assembly, may play dual roles as both a structural protein at the Z-disk, and also as a regulatory protein (possibly through its binding partners) of signaling pathways between both the nucleus and the Z-disk during cardiac development and mechanical stretch. Although both interesting and informative, experiments in H9C2 cells subjected to 2-dimensional strain may partially limit extrapolation of the findings to an intact, 3-dimensional beating heart. Characterizing the timing of key events in assembly of the nebulette interactome during development, perhaps using real-time microscopy with the various mutants, will be worthy of further investigation. Additionally, studies should also aim to determine whether the stretch sensing, signaling, and structural functions of the Z-disk are independent or closely interrelated.

In summary, this exciting study by Purevjav et al. (11) identifies nebulette mutations associated with a continuum of cardiomyopathy phenotypes and severities in humans. Importantly, the study validates the functional effects of the newly identified nebulette mutants in vivo using cardiac transgenic mice, revealing an array of pathologic cardiac phenotypes from neonate to adult. This finding suggests that nebulette is required for normal genesis of the sarcomere and stabilization of the Z-disk during both development and adult cardiac contractility. Further, the study identifies nebulette as an essential component of the stretch sensor machinery contributing to the pathophysiology of DCM and EFE, and opens the door to studying the roles of domain-specific Z-disk interactions affecting mechanical and biochemical pathways for all cardiomyopathy phenotypes.

References

Gautel  M.; The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia. Adv Exp Med Biol. 642 2008:176-191.
PubMed
Jefferies  J.L., Towbin  J.A.; Dilated cardiomyopathy. Lancet. 375 2010:752-762.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Functional dissection of nebulette demonstrates actin binding of nebulin-like repeats and Z-line targeting of SH3 and linker domains. Cell Motil Cytoskeleton. 44 1999:1-22.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. Exp Cell Res. 273 2002:204-218.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Nebulette: a 107 kD nebulin-like protein in cardiac muscle. Cell Motil Cytoskeleton. 32 1995:205-225.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Architecture of the thin filament-Z-line junction: lessons from nebulette and nebulin homologies. J Muscle Res Cell Motil. 21 2000:153-169.
CrossRef | PubMed
Esham  M., Bryan  K., Milnes  J., Holmes  W.B., Moncman  C.L.; Expression of nebulette during early cardiac development. Cell Motil Cytoskeleton. 64 2007:258-273.
CrossRef | PubMed
Li  B., Zhuang  L., Trueb  B.; Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J Biol Chem. 279 2004:20401-20410.
CrossRef | PubMed
Wang  X., Osinska  H., Gerdes  A.M., Robbins  J.; Desmin filaments and cardiac disease: establishing causality. J Card Fail. 8 2002:S287-S292.
CrossRef | PubMed
Holmes  W.B., Moncman  C.L.; Nebulette interacts with filamin C. Cell Motil Cytoskeleton. 65 2008:130-142.
CrossRef | PubMed
Purevjav  E., Varela  J., Morgado  M.; Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol. 56 2010:1493-1502.
CrossRef | PubMed
Bowles  N.E., Bowles  K.R., Towbin  J.A.; The “final common pathway” hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 25 2000:168-175.
CrossRef | PubMed
Arimura  T., Nakamura  T., Hiroi  S.; Characterization of the human nebulette gene: a polymorphism in an actin-binding motif is associated with nonfamilial idiopathic dilated cardiomyopathy. Hum Genet. 107 2000:440-451.
CrossRef | PubMed
Bonzo  J.R., Norris  A.A., Esham  M., Moncman  C.L.; The nebulette repeat domain is necessary for proper maintenance of tropomyosin with the cardiac sarcomere. Exp Cell Res. 314 2008:3519-3530.
CrossRef | PubMed
Fatkin  D., Graham  R.M.; Molecular mechanisms of inherited cardiomyopathies. Physiol Rev. 82 2002:945-980.
PubMed
Kamisago  M., Sharma  S.D., DePalma  S.R.; Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 343 2000:1688-1696.
CrossRef | PubMed
Schmitt  J.P., Kamisago  M., Asahi  M.; Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 299 2003:1410-1413.
CrossRef | PubMed
Cox  L., Umans  L., Cornelis  F., Huylebroeck  D., Zwijsen  A.; A broken heart: a stretch too far. An overview of mouse models with mutations in stretch-sensor components. Int J Cardiol. 131 2008:33-44.
CrossRef | PubMed
Frank  D., Kuhn  C., Katus  H.A., Frey  N.; Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy. Future Cardiol. 3 2007:611-622.
CrossRef | PubMed

Figures

Tables

Interactive Graphics

Video

References

Gautel  M.; The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia. Adv Exp Med Biol. 642 2008:176-191.
PubMed
Jefferies  J.L., Towbin  J.A.; Dilated cardiomyopathy. Lancet. 375 2010:752-762.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Functional dissection of nebulette demonstrates actin binding of nebulin-like repeats and Z-line targeting of SH3 and linker domains. Cell Motil Cytoskeleton. 44 1999:1-22.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. Exp Cell Res. 273 2002:204-218.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Nebulette: a 107 kD nebulin-like protein in cardiac muscle. Cell Motil Cytoskeleton. 32 1995:205-225.
CrossRef | PubMed
Moncman  C.L., Wang  K.; Architecture of the thin filament-Z-line junction: lessons from nebulette and nebulin homologies. J Muscle Res Cell Motil. 21 2000:153-169.
CrossRef | PubMed
Esham  M., Bryan  K., Milnes  J., Holmes  W.B., Moncman  C.L.; Expression of nebulette during early cardiac development. Cell Motil Cytoskeleton. 64 2007:258-273.
CrossRef | PubMed
Li  B., Zhuang  L., Trueb  B.; Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J Biol Chem. 279 2004:20401-20410.
CrossRef | PubMed
Wang  X., Osinska  H., Gerdes  A.M., Robbins  J.; Desmin filaments and cardiac disease: establishing causality. J Card Fail. 8 2002:S287-S292.
CrossRef | PubMed
Holmes  W.B., Moncman  C.L.; Nebulette interacts with filamin C. Cell Motil Cytoskeleton. 65 2008:130-142.
CrossRef | PubMed
Purevjav  E., Varela  J., Morgado  M.; Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol. 56 2010:1493-1502.
CrossRef | PubMed
Bowles  N.E., Bowles  K.R., Towbin  J.A.; The “final common pathway” hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 25 2000:168-175.
CrossRef | PubMed
Arimura  T., Nakamura  T., Hiroi  S.; Characterization of the human nebulette gene: a polymorphism in an actin-binding motif is associated with nonfamilial idiopathic dilated cardiomyopathy. Hum Genet. 107 2000:440-451.
CrossRef | PubMed
Bonzo  J.R., Norris  A.A., Esham  M., Moncman  C.L.; The nebulette repeat domain is necessary for proper maintenance of tropomyosin with the cardiac sarcomere. Exp Cell Res. 314 2008:3519-3530.
CrossRef | PubMed
Fatkin  D., Graham  R.M.; Molecular mechanisms of inherited cardiomyopathies. Physiol Rev. 82 2002:945-980.
PubMed
Kamisago  M., Sharma  S.D., DePalma  S.R.; Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 343 2000:1688-1696.
CrossRef | PubMed
Schmitt  J.P., Kamisago  M., Asahi  M.; Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 299 2003:1410-1413.
CrossRef | PubMed
Cox  L., Umans  L., Cornelis  F., Huylebroeck  D., Zwijsen  A.; A broken heart: a stretch too far. An overview of mouse models with mutations in stretch-sensor components. Int J Cardiol. 131 2008:33-44.
CrossRef | PubMed
Frank  D., Kuhn  C., Katus  H.A., Frey  N.; Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy. Future Cardiol. 3 2007:611-622.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles